EXAS vs RCON · rev $2.76B vs rev $9.3M
EXACT Sciences Corporation (EXAS) versus Recon Technology Ltd (RCON) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Recon Technology Ltd (RCON) is a oil & gas equipment & services company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported RCON revenue for 2025-06-30 was $9.3M. Net income was -$5.9M. Revenue was down 2.3% from 2024-06-30 to 2025-06-30. RCON currently screens at market cap $45.4M.
EXAS currently screens at market cap $20.03B. RCON currently screens at market cap $45.4M.
Not investment advice. Open the EXAS and RCON stock pages for the full models.
Not investment advice.